Michael J. Holtzman, MD received an Outstanding Investigator Award entitled “Defining and Controlling Airway Disease” from the National Institutes of Health, National Heart, Lung, and Blood Institute. This Project aims at reprogramming epithelial stem cells in the lung to understand and prevent respiratory airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). The award will provide $6,608,000 over 7 years for Dr. Holtzman’s research activities.
Michael J. Holtzman, MD receives an Outstanding Investigator Award from NHLBI
